PubMed:26931464 / 781-896 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T86","span":{"begin":15,"end":20},"obj":"CHEBI:23888"},{"id":"T89","span":{"begin":22,"end":32},"obj":"6472"},{"id":"T87","span":{"begin":22,"end":32},"obj":"D008148"},{"id":"T88","span":{"begin":22,"end":32},"obj":"D008148"},{"id":"T90","span":{"begin":22,"end":32},"obj":"CHEBI:40303"},{"id":"T91","span":{"begin":95,"end":114},"obj":"UBERON:0000120"}],"text":"Of these three drugs, lovastatin had the highest lipophilicity, which facilitated crossing the blood-brain barrier."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T6","span":{"begin":0,"end":115},"obj":"DRI_Approach"}],"text":"Of these three drugs, lovastatin had the highest lipophilicity, which facilitated crossing the blood-brain barrier."}